Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms - Archive ouverte HAL Access content directly
Journal Articles Leukemia Year : 2021

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

(1, 2) , (3, 4) , (1, 5)
1
2
3
4
5

Abstract

Thrombosis, both in arterial and venous territories, is the major complication of myeloproliferative neoplasms and is responsible for a high rate of morbidity and mortality. The currently accepted risk factors are an age over 60 years and a history of thrombosis. However, many complex mechanisms contribute to this increased prothrombotic risk, with involvement of all blood cell types, plasmatic factors, and endothelial cells. Besides, some cardiovascular events may originate from arterial vasospasm that could contribute to thrombotic complications. In this review, we discuss recent results obtained in mouse models in the light of data obtained from clinical studies. We emphasize on actors of thrombosis that are currently not targeted with current therapeutics but could be promising targets, i.e, neutrophil extracellular traps and vascular reactivity.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03637351 , version 1 (11-04-2022)

Identifiers

Cite

Alexandre Guy, Johanne Poisson, Chloe James. Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms. Leukemia, 2021, 35 (4), pp.935-955. ⟨10.1038/s41375-021-01170-z⟩. ⟨inserm-03637351⟩
13 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More